Scarica l'app Stockscreener
92.38
0.50%
0.46
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$91.92
Aprire:
$92.58
Volume 24 ore:
1.00M
Relative Volume:
0.44
Capitalizzazione di mercato:
$18.24B
Reddito:
$7.68B
Utile/perdita netta:
$903.80M
Rapporto P/E:
20.76
EPS:
4.45
Flusso di cassa netto:
$1.14B
1 W Prestazione:
+0.23%
1M Prestazione:
+0.12%
6M Prestazione:
-14.49%
1 anno Prestazione:
-18.51%
Intervallo 1D:
$91.97
$92.98
Intervallo di 1 settimana:
$89.24
$92.98
Portata 52W:
$89.24
$116.71
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Confronta ZBH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
92.38 | 18.24B | 7.68B | 903.80M | 1.14B | 4.45 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Zimmer Biomet sued for violating Treace Medical patents related to bunion treatment - MSN
Highridge sells bone healing business to Avista - BioWorld MedTech
Treace Medical Concepts (TMCI) Sues Zimmer Biomet Over Patent Infringements - GuruFocus
Zimmer Biomet Facing Patent Infringement Lawsuit From Treace Medical - marketscreener.com
Treace Medical sues Zimmer Biomet over patent infringement - Investing.com Australia
Treace Medical sues Zimmer Biomet over patent infringement By Investing.com - Investing.com Nigeria
Zimmer Biomet faces patent suit from Treace Medical (TMCI) - Seeking Alpha
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology - The Manila Times
Treace Medical files patent infringement suit against Zimmer Biomet - TipRanks
Treace Medical Concepts Files Patent Infringement Suit Against Zimmer Biomet - marketscreener.com
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Zimmer Biomet Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 31, 2017ZBH - ACCESS Newswire
zimmer biomet shareholders approve stock incentive plan amendments By Investing.com - Investing.com South Africa
Rep. Robert Bresnahan, Jr. Sells Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares - Defense World
zimmer biomet shareholders approve stock incentive plan amendments - Investing.com
Zimmer Biomet Approves Amendments at Annual Meeting - TipRanks
Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24 - Yahoo Finance
Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24 - simplywall.st
Zimmer Biomet sets quarterly dividend at $0.24 per share By Investing.com - Investing.com South Africa
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Knee Replacement Market Detailed in New Research ReportZimmer Biomet, Stryker - openPR.com
Zimmer Biomet Keeps Quarterly Dividend at $0.24 a Share, Payable Around July 31 to Shareholders of Record on June 26 - marketscreener.com
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025 - GuruFocus
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025 | ZBH Stock News - GuruFocus
Zimmer Biomet sets quarterly dividend at $0.24 per share - Investing.com
Zimmer Biomet Q2 2025 Dividend: $0.24 Per Share Payable July 31Key Dates and Details - Stock Titan
Zacks Research Forecasts Weaker Earnings for Zimmer Biomet - Defense World
Zimmer Biomet Chairman, President and CEO Ivan Tornos Joins OREF Board of Trustees - Yahoo Finance
A Look Back at Surgical Equipment & ConsumablesDiversified Stocks’ Q1 Earnings: Zimmer Biomet (NYSE:ZBH) Vs The Rest Of The Pack - Yahoo Finance
Zacks Research Forecasts Reduced Earnings for Zimmer Biomet - Defense World
Zimmer Biomet names Kevin Thornal as group president, global biz - Medical Buyer
Zimmer Biomet Appoints Kevin Thornal as Group President, Global Businesses and the Americas - The Malaysian Reserve
Zimmer Biomet Holdings (ZBH) Appoints Kevin Thornal as Group Pre - GuruFocus
Orthopedic Oncology Market is Booming WorldwideStryker, Zimmer Biomet - openPR.com
Zimmer hires former Nevro CEO Kevin Thornal - Yahoo Finance
Zimmer Biomet Holdings (ZBH) Appoints Kevin Thornal as Group President - GuruFocus
Zimmer Biomet names new Group President for Americas By Investing.com - Investing.com South Africa
Former Nevro CEO joins Zimmer Biomet as group president - MassDevice
Hip Replacement Market is Booming WorldwideZimmer Biomet, Stryker - openPR.com
Zimmer Biomet Appoints Kevin Thornal As Group President, Global Businesses And The Americas - marketscreener.com
Zimmer Biomet Appoints Kevin Thornal as Group President - TipRanks
Zimmer Biomet Appoints Kevin Thornal as Group President, Global Businesses and the Americas | ZBH Stock News - GuruFocus
Zimmer Biomet names new Group President for Americas - Investing.com
Saudi Arabia Dental Implants Market Trends and Forecasts 2020-2024 & 2025-2030, Competitive Analysis of Masar Medical, Keydent, Zimmer Biomet, Dentsply Sirona, and Henry Schein - Yahoo
Zimmer Biomet Holdings (ZBH) Stock Analysis: Navigating a Potential 17.25% Upside in the Healthcare Sector - DirectorsTalk Interviews
Zimmer Biomet’s SWOT analysis: orthopedic giant’s stock navigates challenges By Investing.com - Investing.com Nigeria
Zimmer Biomet’s SWOT analysis: orthopedic giant’s stock navigates challenges - Investing.com
Zimmer Biomet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - The Malaysian Reserve
Zimmer Biomet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference | ZBH Stock News - GuruFocus
ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues - TradingView
Zimmer Biomet Holdings, Inc. (ZBH): Among the Most Oversold Stocks to Buy According to Billionaires - Insider Monkey
Zimmer Biomet Stock Outlook: Is Wall Street Bullish or Bearish? - Nasdaq
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.56%
1.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):